Immediate Impact
4 from Science/Nature 59 standout
Citing Papers
Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial
2025 Standout
Recent advances in Alzheimer’s disease: mechanisms, clinical trials and new drug development strategies
2024 Standout
Works of Roger Morgan being referenced
A phase 1 clinical trial of the sigma‐2 receptor complex allosteric antagonist CT1812, a novel therapeutic candidate for Alzheimer's disease
2018
A phase II dose-ranging study of the phosphodiesterase inhibitor K-134 in patients with peripheral artery disease and claudication
2011
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Roger Morgan | 108 | 19 | 27 | 91 | 43 | 22 | 303 | |
| Lloyd Stevens | 54 | 6 | 72 | 29 | 14 | 309 | ||
| K‐S Yu | 53 | 1 | 9 | 93 | 31 | 14 | 370 | |
| P Riant | 29 | 13 | 3 | 115 | 23 | 26 | 360 | |
| Anup Kumar Das | 76 | 5 | 3 | 58 | 107 | 31 | 368 | |
| Aubrey Stoch | 30 | 5 | 17 | 53 | 27 | 16 | 321 | |
| A Ramachandran | 28 | 11 | 9 | 43 | 45 | 17 | 281 | |
| Rebecca Vella | 53 | 18 | 4 | 76 | 59 | 31 | 288 | |
| Roda Plakogiannis | 73 | 24 | 35 | 49 | 53 | 20 | 272 | |
| Mohamed Ben‐Eltriki | 78 | 48 | 8 | 89 | 34 | 26 | 337 | |
| Bani Tamraz | 43 | 4 | 8 | 34 | 19 | 20 | 332 |
All Works
Loading papers...